Bioengineering on the Firing Line: Hemodialysis in the 1960s and 1970s at the University of Washington - Clinical, Engineering, and Ethical Considerations in Delivering New Medical Technology

BIOMEDICAL ENGINEERING AT THE MILLENNIUM, SEATTLE, WASHINGTON, 12-14 OCTOBER 2000

SPECIAL LUNCH HISTORIC SESSION
Thursday, 12 October Northwest Ballroom 3
12 noon to 2 PM

PANEL MEMBERS
Paul Fagette, Ph.D., Chair Belding H. Scribner, M.D.
Christopher Blagg, M.D.
Wayne Quinton, Founder Quinton Instruments
Reverend John B. Darrah

HONORED INVITED GUEST
Les Babb, Ph.D.

SPECIAL THANKS TO  

CHRISTOPHER BLAGG, MD

FRANCIS "SANDY" SPELMAN, MEETING CHAIR, BMES 2000 

NITISH V. THAKOR, PROGRAM CHAIR, BMES 2000 

PAT HORNER, EXECUTIVE SECRETARY, BMES 

HERB VOIGT, PRESIDENT, BMES

 

 




This year's historic session highlights the signal accomplishments of engineers and clinicians in the treatment for uremia with hemodialysis in the 1960s and 1970s. The panel will present and discuss the achievements of notables working at the University of Washington - engineers Les Babb and Wayne Quinton and physicians Belding Scribner and Christopher Blagg. The role of the University of Washington stands as a hallmark in this period. The panel has two goals regarding research and treatment for dialysis. First, to present and document a significant historic event in the history of biomedical engineering surrounding the events, the science, and the personnel at the University. Second, present this historic event to the biomedical engineering community including its students to enable them to understand the crucial links between the medical and engineering communities and that their research and subsequent clinical action can have ethical considerations.

Presentations include an introduction and short historical overview by Paul Fagette. Christopher Blagg, a leading physician in this effort, presents the clinical need and the direction of clinical research. Wayne Quinton presents the engineering contribution of technological solutions. Reverend John  Darrah  discusses the ethical issues raised with the dialysis treatment program regarding access to treatment. He chaired the committee that reviewed cases submitted for treatment during those years when patient demand outstripped supply.  Belding Scribner offers an overview of the clinical effort.

 

 

BMES 2000 Home